You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 101 No. 2, February 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Fluorouracil: Mechanism of Action in Human Skin and Actinic Keratoses

I. Effect on DNA Synthesis in Vivo

William H. Eaglstein, MD; Gerald D. Weinstein, MD; Phillip Frost, MD

Arch Dermatol. 1970;101(2):132-139.


Abstract

Normal skin and actinic keratoses were exposed to fluorouracil in order to study its effect on deoxyribonucleic acid (DNA) synthesis. Using intradermally injected tritiated deoxyuridine and autoradiography, we have demonstrated that fluorouracil blocks DNA synthesis in vivo by inhibiting thymidylate synthetase activity. Fluorouracil administered intradermally blocks DNA synthesis in both normal skin and actinic keratoses. Applied topically, and topically with occlusion, fluorouracil inhibits DNA synthesis for two and four hours respectively in actinic keratoses. An estimated minimum tissue concentration of 10-4 to 10-5 M of fluorouracil was required to inhibit thymidylate synthetase activity in human skin. Possible correlation of this biochemical effect with the clinical action of fluorouracil on actinic keratoses is discussed.



Author Affiliations

Miami, Fla

From the Department of Dermatology, University of Miami School of Medicine, Miami, Fla.


Footnotes

Accepted for publication Sept 9, 1969.

Reprint requests to Department of Dermatology, University of Miami School of Medicine, PO Box 875, Biscayne Annex, Miami, Fla 33152 (Dr. Weinstein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Comparison of the Efficacy and Safety of Jessner's Solution and 35% Trichloroacetic Acid vs 5% Fluorouracil in the Treatment of Widespread Facial Actinic Keratoses
Lawrence et al.
Arch Dermatol 1995;131:176-181.
ABSTRACT  

Treatment of Lip Keratoses (Actinic Cheilitis) With Topical Fluorouracil
Epstein
Arch Dermatol 1977;113:906-908.
ABSTRACT  

Allergic Contact Dermatitis From Topical Fluorouracil
Goette et al.
Arch Dermatol 1977;113:196-198.
ABSTRACT  

Noninflammatory Destruction of Actinic Keratoses by Fluorouracil
Breza et al.
Arch Dermatol 1976;112:1256-1258.
ABSTRACT  

Basal-Cell Carcinoma: A Case Unmasked by Systemic Fluorouracil Therapy
Scialla and Miskoff
JAMA 1976;235:2416-2417.
ABSTRACT  

Effects of Topical Fluorouracil on Normal Skin
Zelickson et al.
Arch Dermatol 1975;111:1301-1306.
ABSTRACT  

Erythroplasia of Queyrat: Treatment With Topically Applied Fluorouracil
Goette et al.
JAMA 1975;232:934-937.
ABSTRACT  

Successful Topical Treatment of an Unusual Ulcer With Fluorouracil
Nordlund and Klaus
Arch Dermatol 1972;106:390-392.
ABSTRACT  

Methotrexate: Mechanism of Action on DNA Synthesis in Psoriasis
Weinstein et al.
Arch Dermatol 1971;104:236-243.
ABSTRACT  

Bullous Pemphigoid Following the Topical Use of Fluorouracil
Bart and Bean
Arch Dermatol 1970;102:457-460.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.